Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00311324 · ClinicalTrials.gov registry record · NA
A Church Based Intervention to Improve Diabetes Care
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
NCT00311324: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT00311324 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 201 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00311324, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
Study Summary
The purpose of this study it to determine if a culturally appropriate, church based intervention for African Americans with type 2 diabetes, will lead to improved glycemic (blood sugar) control.
Primary Outcome
5 µL capillary blood collected using standard finger-stick technique and assessed by automated affinity high-performance liquid chromatography.
Interventions
- BEHAVIORAL Delayed Intervention
- BEHAVIORAL Special Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2001-02 |
| Est. Completion | 2003-08 |
| Phase | NA |
What the finished NCT00311324 record still lists
NCT00311324 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Delayed Intervention is the first listed.
NCT00311324 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00311324 about?
NCT00311324 is a clinical study titled "A Church Based Intervention to Improve Diabetes Care". The purpose of this study it to determine if a culturally appropriate, church based intervention for African Americans with type 2 diabetes, will lead to improved glycemic (blood sugar) control.
What is the current status of trial NCT00311324?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2001-02. Estimated completion is 2003-08.
What interventions are being tested in trial NCT00311324?
The interventions under investigation include: Delayed Intervention (BEHAVIORAL), Special Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00311324?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00311324's enrollment target sits among peer trials
201 506th of 2000 higher than 1,495 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia